Group One Trading
CLOV icon

Group One Trading’s Clover Health Investments CLOV Stock Holding History

Group One Trading’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Sell
709,300
-1,769,100
-71% -$3.84M ﹤0.01% 2497
2025
Q4 		$5.82M Buy
2,478,400
+1,255,500
+103% +$3.43M 0.01% 1346
2025
Q3 		$3.74M Sell
1,222,900
-69,300
-5% -$198K 0.01% 1751
2025
Q2 		$3.61M Sell
1,292,200
-321,200
-20% -$1.06M 0.01% 1597
2025
Q1 		$5.79M Sell
1,613,400
-88,100
-5% -$354K 0.02% 962
2024
Q4 		$5.36M Buy
1,701,500
+229,100
+16% +$819K 0.01% 1111
2024
Q3 		$4.15M Buy
1,472,400
+731,700
+99% +$1.67M 0.01% 1143
2024
Q2 		$911K Buy
740,700
+264,500
+56% +$237K ﹤0.01% 2065
2024
Q1 		$378K Sell
476,200
-105,600
-18% -$96.1K ﹤0.01% 3004
2023
Q4 		$554K Buy
581,800
+74,200
+15% +$72.9K ﹤0.01% 2986
2023
Q3 		$548K Buy
507,600
+138,500
+38% +$165K ﹤0.01% 2818
2023
Q2 		$331K Buy
369,100
+258,700
+234% +$229K ﹤0.01% 3436
2023
Q1 		$93.3K Sell
110,400
-207,200
-65% -$227K ﹤0.01% 4365
2022
Q4 		$295K Sell
317,600
-48,500
-13% -$64.7K ﹤0.01% 3509
2022
Q3 		$622K Sell
366,100
-132,000
-27% -$346K ﹤0.01% 3026
2022
Q2 		$1.07M Sell
498,100
-946,000
-66% -$2.51M ﹤0.01% 2692
2022
Q1 		$5.13M Buy
1,444,100
+554,200
+62% +$1.61M 0.01% 1531
2021
Q4 		$3.31M Sell
889,900
-877,500
-50% -$5.38M ﹤0.01% 2081
2021
Q3 		$13.1M Sell
1,767,400
-1,895,900
-52% -$16.2M 0.01% 875
2021
Q2 		$48.8M Buy
3,663,300
+2,011,200
+122% +$19.8M 0.06% 259
2021
Q1 		$12.5M Buy
1,652,100
+797,100
+93% +$9M 0.02% 799
2020
Q4 		$14.3M Buy
+855,000
New +$9.52M 0.02% 595

Other funds holding CLOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Group One Trading's CLOV Position: Q1 2026 in Review

Group One Trading reduced its Clover Health Investments (CLOV) stake by 46% in Q1 2026, selling an estimated $1.09M and leaving 587,104 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2685.

Group One Trading first reported a position in CLOV in Q4 2020 and has held it in 19 quarters since. The position peaked at $32.1M in Q4 2020. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Group One Trading held 587,104 shares of Clover Health Investments worth $1.03M as of Q1 2026.
  • Group One Trading sold 500,871 Clover Health Investments shares in Q1 2026, an estimated $1.09M.
  • Clover Health Investments made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2685 holding.
  • Group One Trading first reported a position in Clover Health Investments in Q4 2020 and has held it in 19 quarters since.
  • Group One Trading's Clover Health Investments position peaked at $32.1M in Q4 2020.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.